0958 ET -- Bristol Myers Squibb is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The drugmaker has agreed to buy radiopharmaceutical therapeutics company RayzeBio for $4.1 billion. Dow Jones & Co. owns Factiva. (colin.kellaher@wsj.com)

(END) Dow Jones Newswires

December 26, 2023 10:13 ET (15:13 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Bristol Myers Squibb Charts.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Bristol Myers Squibb Charts.